European Archives - Page 123 of 1370 - European Medical Journal

Month in pharma news, explained

Month in pharma news, explained – September 2025

Read this month’s pharma news roundup, featuring AI in healthcare risks, GLP-1 drug trials beyond obesity and Trump’s US tariffs.

Menopause Does Not Accelerate Disability in Multiple Sclerosis

Discover a new study showing that menopause does not accelerate disability in women with multiple sclerosis, offering reassurance for patients at midlife.

Decipher Genomic Classifier in Focal Therapy

Recurrence rates remain a concern, with up to one third of men experiencing disease return within two years.

Understanding Atopic Dermatitis: Astrid Haaskjold Lossius

 Our aim is to improve treatment adherence and address psychological barriers such as steroid phobia by increasing knowledge and confidence around AD care…

Retifanlimab Improves Survival in Metastatic Lung Cancer Trial

A phase 3 trial found that retifanlimab plus chemotherapy significantly improved survival in patients with metastatic NSCLC, with a safety profile consistent with other PD-1 inhibitors.

Microwave ablation, thyroid

Microwave Ablation Effective for Benign Thyroid Nodules

Microwave ablation is a safe, effective treatment for benign thyroid nodules and AFTNs.

Diabetes Not a Barrier for PCI with Orbital Atherectomy

Coronary orbital atherectomy is safe and effective for severe heart disease, even in patients with diabetes, real-world study shows.

mutation

TP53 Mutations Reshape the Lung Adenocarcinoma Tumour Microenvironment

Study reveals how TP53 mutations alter lung adenocarcinoma tumour microenvironment, influencing progression and immunotherapy response.

Maternal Mediterranean Diet and Food Allergy Prevention

Food allergies are now considered the “second wave” of the allergy epidemic, following asthma, and they disproportionately affect infants and young children.

GLP-1RA, Lupus

GLP-1RA Shows Cardiovascular and Kidney Benefits in Lupus

GLP-1RA use lowered cardiovascular, kidney, and mortality risks in patients with lupus and diabetes